Mammography Market Analysis

Global Mammography Market Overview

The mammography market size was valued at USD 2.5 Billion in 2022. The mammography industry is projected to grow from USD 2.73 Billion in 2023 to USD 5.54 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.25% during the forecast period (2023 - 2032). The increasing prevalence of breast cancer, increasing demand for early-stage diagnosis amongst patients, high R&D investments in breast cancer treatments, and expansions in breast imaging modalities are the key market drivers enhancing the market growth.

Source Secondary Research, Primary Research, MRFR Database, and Analyst Review

A pioneer in GPT AI assistance for mammography quality, intelliMaven will go on sale in 2024, according to Densitas, a leading global provider of AI solutions for breast cancer screening. IntelliMaven, in conjunction with Densitas' flagship product intelliMammo, offers mammography facilities scalable and long-lasting quality assurance to satisfy ACR accreditation standards and FDA MQSA EQUIP compliance. Densitas is transforming the way technologists hone their skills in an industry first. According to the unique training requirements and learning path of every techie, intelliMaven provides customized advice.

This week at the annual radiology and medical imaging conference, RSNA 2023, in Chicago, GE HealthCare unveiled a new AI suite. The new tool, known as the MyBreastAI suite, is intended to make radiologists' tasks easier and assist them in identifying breast cancer. The FDA has approved and approved Hologic's Genius artificial intelligence (AI) software for tomosynthesis-based early breast screening in 2020. The program is currently available for purchase. The Hologic 3D Mammography system is the operating system for the computer-aided detection (CAD) software. The business released a statement claiming that Genius AI is the only CAD program that works with its most sophisticated packages for breast tomosynthesis, Clarity HD and 3DQuorum imaging technology.

In December 2023, MammogramNow, a first-of-its-kind screening mammography service by RadNet, Inc. to go live at the Milford Walmart Supercenter in Delaware, is introduced.

For example, in November 2023, GE HealthCare unveiled the MyBreastAI suite during the RSNA 2023 Chicago conference. The AI-driven system’s goal is to optimize radiologists’ workflow and help them diagnose breast cancer in its early stages. These technological innovations in mammography influence the demand for mammography films.

Siemens Healthineers released the Mammomat B.brilliant1 with wide-angle tomosynthesis in September 2023. The advanced mammography system is built around a wide 50° angle for tomosynthesis -the largest available on the market – which enables rapid generation of high-depth resolution images via a scan time of about five seconds.

GE Healthcare also introduced three global innovations in May 2023. These include Intelligent Radiation Therapy (IRT), Auto Segmentation, and an updated Magnetic Resonance (MR) Radiation Therapy Suite (AIR Open Coil Suite). These were showcased at the ESTRO 2023 Congress, European Society for Therapeutic Radiology and Oncology. They have been designed to support healthcare providers so that they can deliver highly-personalized care by creating access to diagnostics, technologies and crucial information upon which their decisions are based confident enough with the hope of assisting patients to lead healthy lives.

Siemens Healthineers’ manufacturing facility expansion was announced in June 2023. In relation to this plan, as it has set up its new production line (plant) for Computed Tomography Scanners at its Bengaluru site, the company aimed to boost the growth of medical devices area within India.

The Merit Health Woman’s Hospital underwent installation of a new specimen imaging center using 3D Tomosynthesis technology specifically meant for breast tissue specimens in May 2022 for better visualization of tumors during lumpectomy surgeries.

Mammography Market Trends

• The rising incidence of breast cancer is driving the market growth

Market CAGR for mammography is driven by the rising incidence of breast cancer in developed and developing countries. This rising incident has increased the demand for technologically advanced instruments focusing on early detection. The growing number of breast cancer patients has pushed governments across the globe to increase awareness regarding the significance of the early detection of breast cancer. As per the American Cancer Society, breast cancer is the second largest cause of cancer-related deaths in women across the world. Around 2,261,419 new breast cancer cases were diagnosed in women, and 684,996 women died due to breast cancer worldwide in 2020.

Favorable initiatives for breast cancer screening or an increase in the number of breast cancer screening programs or campaigns are expected to boost the growth of the  mammography market. For instance, in October 2020, the Kao Group of Japan launched the 'Kao Group Pink Ribbon Campaign 2020' in prominent cities across Japan. The campaign has been operating since 2007 to convey the significance of early detection of breast cancer to as multiple people as possible. Breast cancer is presently the most common type of cancer in Japanese females, driving the growth of the mammography market revenue.

The rising incidence of breast cancer is creating a higher demand for mammography as it is an essential screening element for early detection and diagnosis. The need for timely and accurate breast cancer detection is driving the growth of the mammography market. Governments and healthcare organizations are implementing breast cancer screening programs and awareness campaigns to promote early detection and reduce breast cancer-related mortality. These initiatives and reimbursement policies drive the demand for mammography services and contribute to market growth. Increasing healthcare expenditure in many countries and improved access to healthcare services are boosting the demand for mammography. Investments in healthcare infrastructure, advancements in medical technology, and growing disposable incomes support the market's growth.

Advancements in technology and computer programming have led to an increased involvement of computer-automated analyses in medical image interpretation. This is driven by the need for more accurate and efficient workflows in imaging interpretation. In breast imaging, FDA-approved artificial intelligence (AI) algorithms are employed to support radiologists. AI automatically scans all breast photos, identifying regions of interest that may include suspicious malignancies, driving the market growth.

Mammography Market Segment Insights

Mammography Type Insights

The mammography market segmentation, based on type, includes screening mammography and diagnostic mammography. The diagnostic mammography segment dominated the market, accounting for 35% of market revenue (0.96 Billion). In developing economies, segment growth is driven by the presence of skilled and experienced healthcare professionals who can provide high-quality diagnostic services. However, screening mammography is the fastest-growing category due to the expansion in the screening procedure.

Mammography Technology Insights

The mammography market segmentation, based on technology, includes 2-D technology, 3-D technology, and combination technology. The 3-D technology category generated the most income (70.4%) owing to technological benefits, including the ability to manage bigger procedure volumes, increased breast cancer detection rates, and a more advantageous reimbursement scenario. However, combination technology is the fastest-growing category due to its superior depiction of low-contrast things, more comprehensive dynamic change, and improved diagnostic quality of images.

Mammography Product Insights

The mammography market segmentation, based on product, includes digital systems, analog systems, breast tomosynthesis, film screen systems, and others. The breast tomosynthesis category generated the most income as digital breast tomosynthesis is a high-resolution limited-angle tomography advancement that utilizes X-rays to develop a 3-dimensional breast image. However, the digital system is the fastest-growing category owing to its superior depiction of low-contrast objects, wider dynamic change, and expanded diagnostic quality of images.

Mammography End-User Insights

The mammography market segmentation, based on end-user, includes hospitals, specialty clinics, research institutes, diagnostic centers, and others. The diagnostic center category generated the most income due to increased awareness about breast cancer. However, hospitals are the fastest-growing category due to the existence of mammography facilities within a hospital can positively affect numerous factors, such as duration of hospital stay, quality of care, total healthcare cost, and availability of emergency care.

Figure 1 Mammography Market, by Distribution Channel, 2022 & 2032 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database, and Analyst Review

Mammography Regional Insights

By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American mammography market will dominate owing to high R&D investments in breast cancer therapies, an enhanced prevalence of breast cancer, and developments in breast imaging modalities that will boost the market growth in this region. Further, the German mammography market held the largest market share, and the UK mammography market was the fastest-growing market in the North American region.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2 MAMMOGRAPHY MARKET SHARE BY REGION 2022 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database, and Analyst Review

Europe's mammography market accounts for the second-largest market share due to the availability of the most delinquent mammography systems, improved healthcare facilities, increased healthcare expenditure, and rising per capita income. Further, the German mammography market held the largest market share, and the UK mammography market was the fastest-growing market in the European region.

The Asia-Pacific mammography market is expected to grow at the fastest CAGR from 2023 to 2032. This is due to the presence of well-established healthcare facilities, and increasing awareness about the importance of early diagnosis of breast cancer will boost the market growth. Moreover, China’s mammography market held the largest market share, and the Indian mammography market was the fastest-growing market in the Asia-Pacific region.

Mammography Key Market Players & Competitive Insights

Key market players are supporting heavily R&D to extend their product lines, which will support the mammography market growth even more. Market participants are also undertaking multiple strategic activities to enhance their footprint ly, with important market developments such as new product launches, consolidations and acquisitions, higher investments, contractual agreements, and collaboration with other enterprises. To enhance and survive in a more competitive and rising market climate, the mammography industry must deliver cost-effective items.

Manufacturing locally to minimize operational prices is one of the major business tactics manufacturers utilize in the mammography industry to benefit clients and increase the market sector. Major players in the Mammography market, including Canon Inc., FUJIFILM Holdings Corporation, GENERAL MEDICAL ITALIA, Siemens Healthcare, Villa Systems Medical SpA, and others, are attempting to enhance market demand by investing in research and development operations.

Fujifilm Corp is a provider of imaging and information solutions. The company's product portfolio includes optical devices, digital cameras, photographing sensitive materials, functional films, imaging sensor materials, graphic systems, recording media, touchscreen panel materials, nutritional supplement products, hair care products, X-ray imaging devices, ultrasound devices, interchangeable lenses for digital cameras, electronic materials and industrial products, and office printers. Fujifilm business products include medical systems, graphic systems, optical devices, recording media, industrial products, display materials, and inkjets. It sells its products to individual consumers and business enterprises. In October 2021, FUJIFILM Canada Inc. received a Health Canada medical device license for its ASPIRE Cristalle digital mammography solution. It also expanded its partnership with Christie Innomed to offer the product across every province in Canada.​

Hologic Inc manufactures, develops, and supplies diagnostic products, medical imaging systems, and surgical products. It delivers products that aid the diagnosis of human diseases, GYN surgical products, breast imaging, and related products and accessories, such as endometrial ablation systems and hysteroscopic tissue removal systems, and skeletal health products, including mini C-arm imaging products, and dual-energy X-ray bone densitometry systems. The firm offers solutions to surgeons, clinical laboratories, hospitals, and healthcare providers. Hologic delivers its products and services via direct deals and a network of independent distributors and sales agents. In December 2020, Hologic Inc. proclaimed U.S. FDA approval for its Genius AI Detection technology, a unique deep learning-based software developed to aid radiologists in noticing subtle potential cancers in breast tomosynthesis images.

Key Companies in the Mammography market include

• GE Healthcare


• Koninklijke Philips NV


• Hologic, Inc.


• Gamma Medica, Inc.


• Konica Minolta Business Solutions India Private Limited


• Carestream Health.


• BMI Biomedical International SRL


• Canon Inc


• FUJIFILM Holdings Corporation


• GENERAL MEDICAL ITALIA


• Siemens Healthcare


• Villa Systems Medical SpA.

Mammography Industry Developments

June 2023

Siemens Healthineers expanded its manufacturing facilities in India. It sought to boost the expansion of the country's medical equipment market by launching a new production line (plant) for computed tomography scanners at its Bengaluru site.

May 2023

GE HealthCare launched three new worldwide innovations: Intelligent Radiation Therapy (IRT), Auto Segmentation, and an upgraded Magnetic Resonance (MR) Radiation Therapy Suite (AIR Open Coil Suite), demonstrating the company's commitment to improving the radiation oncology treatment pathway.

Mammography Market Segmentation

Mammography Type Outlook

• Screening Mammography


• Diagnostic Mammography

Mammography Technology Outlook

• 2-D Technology


• 3-D Technology


• Combination Technology

Mammography Product Outlook

• Digital System


• Analog Systems


• Breast Tomosynthesis


• Film Screen Systems


• Others

Mammography End-User Outlook

• Hospitals


• Specialty Clinics


• Research Institutes


• Diagnostic Center


• Others

Mammography Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America